Refex Life Sciences Private Limited - Due diligence report

A 360° intelligence report on Refex Life Sciences Private Limited: trust score, financial health, credit view, compliance, directors, growth…

2021-03-03 Chennai, Tamil Nadu Active Unlisted Active Compliant
Share
Connect MCP
RL Refex Life Sciences Private Limited
Full Due-Diligence Report + Documents
  • Unlock all financial figures & 5-year trends
  • Full trust, health & credit-risk scores
  • Director details, charges & MCA documents
₹700 ₹449 Save ₹251 excl. GST
Or from ₹279/report with credits View credit packages
Company Credits – Starter
  • One credit unlocks this full due-diligence report
  • Use across any company’s report, anytime
  • Credits valid for 12 months
× ₹700 ₹279 = ₹2,790 60% off
Choose your own credit amount View credit packages

Refex Life Sciences Private Limited — 360° Intelligence Report

Generated from MCA filings & public records
78/100
Trust Score
Low Risk

Refex Life Sciences Private Limited is assessed as Low Risk with a Trust Score of 78/100. Refex Life Sciences Private Limited is an active private limited indian non-government company incorporated in 2021, operating in the Chemicals and Materials sector. The company has shown revenue growth across its recent filed years. It reported a loss in its latest filed year. Based on MCA filings and public records, it currently shows a low compliance risk and moderate financial risk profile.

Report generated on 09 Aug 2026 from the latest processed filings. Refex Life Sciences Private Limited snapshot & full profile →

Financial Health › Good
Overall Assessment CautionWeakNeutralGoodStrong Strong
Compliance › Strong

Automated indicators derived from public MCA / GST / EPFO records - not a credit rating, not investment, legal or financial advice. Spotted an inaccuracy? Report an error.

02

Score Card

Higher is safer · rule-based & explainable
Trust ScoreLow Risk
78/100
Overall counterparty trust - the headline number of this report.
Compliance ScoreLow Risk
93/100
Statutory standing - status, filings, auditor, MSME and litigation.
Financial Health ScoreModerate
55/100
Profitability, leverage and liquidity from filed statements.
Credit Risk ScoreCaution Indicated
30/100
Debt capacity, gearing and security cover for lenders.
Director Stability ScoreLow Risk
85/100
Board strength, DIN status, churn and network.
Growth ScoreLow Risk
80/100
Revenue, profit, asset and hiring momentum.
Distress ScoreLow Risk
75/100
Early-warning signals - higher means fewer warnings.
03

Financial Intelligence Dashboard

Standalone · 3 filed year(s)

Unlock the full 5-year financial dashboard with charts and year-wise figures.

Get full access

Scores and observations on this page are already computed from the real filings - only the underlying figures are locked.

04

Credit & Compliance Intelligence

Why the scores are what they are
Credit Risk Score: 30/100 Caution Indicated
  • Negative operating earnings - debt service depends on external support.
  • Open charges exceed net worth - secured lenders rank ahead.

Charges position: 2 open (460.00 cr) · 0 satisfied (-).

Banking relationships (from registered charges)
LenderChargesAmount
Others2 48.0 cr
Compliance Score: 93/100 Low Risk
  • Company status is Active as per MCA.
  • Annual filings current (balance sheet Mar 2025).
  • Litigation present in 1 court forum(s).
  • 1 active GST registration(s).
Legal cases on record (1)
05

Director Intelligence

Stability score: 85/100
NameDIN / PANDesignationAppointedTenureDIN status
ANIL JAIN 01234567 Director 01/04/2018 6 yrs Approved
DINESH KUMAR AGARWAL 01234567 Director 01/04/2018 6 yrs Approved
Praveen Kumar 01234567 Director 01/04/2018 6 yrs Approved
  • 3 directors on the board.
  • No disqualified or deactivated DINs.
  • 2 director exit(s) in the last 3 years.
06

Ownership & Group Intelligence

As per FY 2023 annual return
Promoter holding
64.27%
Public / other holding
35.73%
Equity shares
12,45,67,890
Equity paid-up
124.5 cr
Promoters on record
4
Ultimate holding entity
Sherisha Technologies Private Limited
Subsidiaries
-
Group entities
-
Capital events
1 allotment(s) · 2 transfer(s)

Promoters hold a dominant controlling stake - exact percentages are part of the full report.

Group entityRelationship% held
Sherisha Technologies Private Limited Holding Company 74.00%

Full shareholding pattern, group structure & capital events →

07

Risk Intelligence Center

Growth 80 · Distress 75
Growth signals & trust indicators
Revenue acceleration: +38% over 2 year(s).
Latest year revenue grew 1.42.
Operating for 5 years.
Active EPFO - real payroll on record.
Active GST registration(s).
Distress signals & risk flags
Losses deepening year-on-year.
2 open charge(s) registered - assets are encumbered.
1 court case(s) on record - see the legal section for details.
08

Stakeholder Verdicts

Vendor · Banker · Investor
Vendor due diligence83/100
Favourable indicators
Suitability as a supplier / customer counterparty.
  • Statutory record is clean.
  • 1 distress signal(s) - see Risk Center.
  • Financial filings available for verification.
Banker assessment53/100
Mixed indicators - deeper appraisal suggested
Indicative lending comfort for banks, NBFCs and trade credit.
  • Debt capacity assessed from filed statements.
  • 2 open charge(s) of 460.00 cr already registered.
  • Compliance record supports lending.
Investor view71/100
Positive growth indicators
Growth quality and scalability through an investor lens.
  • 2 growth signal(s) detected.
  • Margin and return trends computable from filings.
  • Management team looks stable.
09

MCA Filings & Events Timeline

Latest 15 events
11 Nov 2025
Director appointed
ANIL JAIN (Additional Director)
30 Sep 2025
Last AGM held
Annual general meeting
30 Jul 2025
Charge created
Others - 335.00 cr
31 May 2025
Director appointed
Praveen Kumar (Company Secretary)
31 Mar 2025
Latest balance sheet
Filed with ROC
01 Jun 2024
Director ceased
PASUPATHY PUTHUSERI VEEDU
25 Sep 2023
Director ceased
PATRIK VIJAY KUMAR FRANCIS ARUN KUMAR
17 May 2023
Charge created
Others - 125.00 cr
05 Oct 2022
Director ceased
CHANDRESH JAIN
31 Mar 2022
Share transfer (FY 2022)
999999.00000000 shares to Sherisha Technologies Private Limited
Share transfer (FY 2022)
1.00000000 shares to Sherisha Technologies Private Limited
01 Nov 2021
Securities allotted
130000000 Debentures - 130.00 cr raised
07 Jun 2021
Director ceased
ANIL JAIN
03 Mar 2021
Incorporated
Registered with Roc Chennai
Director appointed
DINESH KUMAR AGARWAL (Director)
10

Key Observations

Auto-generated from the data above
Revenue grew 2.1x over the last 2 financial year(s).
Debt-to-equity stands at 24% - leverage worth monitoring.
Net worth is positive.
Compliance record is strong - status, filings and flags are clean.
3 active director(s) / partner(s); board looks stable and experienced.
1 active GST registration(s) indicate ongoing business operations.
EPFO-registered employer - verifiable payroll history exists.
Promoters hold a dominant controlling stake as per the FY 2023 annual return.
Capital has been raised through 1 security allotment(s) - amounts available in the full report.
11

Peers & Related Companies

Full peer comparison →
CompanyCINLocation
Flowchem Pvt Ltd U24110TG1982PTC003641 Hyderabad, Telangana, India
Altius Biochem Private Limited U24231GJ2021PTC122626 Ahmedabad, Gujarat, India
Godha Chemicals Pvt Ltd U24231RJ1990PTC005666 Udaipur, Rajasthan, India
Jan Med India Pharma Private Limited U33100TZ2021PTC037476 Erode, Tamil Nadu, India
Archita Industries Private Limited U15100UP1998PTC023242 Uttar Pradesh, Uttar Pradesh, India
Bombay Video Pvt Ltd U92110MH1984PTC031812 Mumbai, Maharashtra, India
Sunshine Aromatic Private Limited U23200AS2007PTC008409 Singra, Assam, India
Fytomax Nutrition Private Limited U15549MH2020PTC416897 Mumbai, Maharashtra, India
12

Who Uses This Report

CA · CS · Banker · Investor · Vendor
Chartered Accountants (CA)

Verify Refex Life Sciences Private Limited before audits and certifications: compliance score 93/100, filing history, auditor history and charge records in one place - instead of pulling each MCA form separately.

Company Secretaries (CS)

Track statutory health of Refex Life Sciences Private Limited: ACTIVE compliance status, annual-return recency, director DIN status, board churn and the events timeline - the inputs for secretarial audits and due-diligence certificates.

Bankers & NBFCs

Current banker verdict: Mixed indicators - deeper appraisal suggested. Credit risk score 30/100, existing charge position and lender relationships - a first-pass credit memo before formal appraisal.

Investors & Analysts

Investor view: Positive growth indicators. Growth score 80/100, margin trends, ownership structure and peer set for Refex Life Sciences Private Limited - screening before a deeper diligence.

Vendors & Procurement Teams

Vendor verdict: Favourable indicators. Trust score 78/100, distress signals and MSME payment-delay disclosures - know whether Refex Life Sciences Private Limited pays its suppliers before you extend credit terms.

Lawyers & Compliance Teams

Litigation footprint (1 case(s) on record), regulatory flags, charge documents trail and director networks for Refex Life Sciences Private Limited - groundwork for KYC, onboarding and disputes.

13

Frequently Asked Questions

Is Refex Life Sciences Private Limited an active company?

Refex Life Sciences Private Limited has MCA status “Active” with a compliance score of 93/100 (Low Risk).

Is Refex Life Sciences Private Limited financially healthy?

Refex Life Sciences Private Limited has a Financial Health Score of 55/100 (Moderate) based on its filed financial statements.

Should I do business with Refex Life Sciences Private Limited?

Its overall Trust Score is 78/100 (Low Risk). Vendor verdict: Favourable indicators. Review the risk flags in the Risk Intelligence Center before deciding.

Who controls Refex Life Sciences Private Limited?

The ultimate holding entity is Sherisha Technologies Private Limited. 3 active director(s) are on record.

Does Refex Life Sciences Private Limited have loans or charges against its assets?

2 open charge(s) are registered against its assets.

Is Refex Life Sciences Private Limited up to date with its ROC filings?

Annual filings current (balance sheet Mar 2025). Overall compliance score: 93/100 (Low Risk).

Is it risky to lend to Refex Life Sciences Private Limited?

Its Credit Risk Score is 30/100 (Caution Indicated). Banker verdict: Mixed indicators - deeper appraisal suggested.

Disclaimer: This report is generated automatically from MCA filings and public records as available in our system at the time of the last update. Scores, bands and verdicts are rule-based derived indicators of the underlying data - they are opinions generated by an algorithm, not statements of fact about the company, and are not credit ratings (within the meaning of SEBI regulations), audits, or investment, legal or financial advice. Verify from official sources and consult a qualified professional before any business, lending or investment decision. If you represent this company and believe any information is inaccurate or outdated, report it here and we will review promptly.